Breaking News Instant updates and real-time market news.

TRHC

Tabula Rasa HealthCare

$25.66

-0.38 (-1.46%)

16:46
09/20/17
09/20
16:46
09/20/17
16:46

Tabula Rasa HealthCare price target raised to $29 from $20 at Piper Jaffray

Piper Jaffray analyst Sean Wieland raised his price target on Tabula Rasa to $29 from $20 to reflect the benefits of the SinfoniaRx acquisition over the next twelve months. Wieland reiterated his Overweight rating, saying he believes 20% revenue growth is achievable due to the opportunities the acquisition creates, and further potential catalysts include "announcements of milestone achievements on the current EMTM pilot, further expansion beyond the core business, and any upward revisions to guidance."

  • 25

    Sep

TRHC Tabula Rasa HealthCare
$25.66

-0.38 (-1.46%)

07/10/17
CHDN
07/10/17
INITIATION
Target $19.5
CHDN
Buy
Tabula Rasa HealthCare initiated with a Buy at Chardan
Chardan analyst Steven Wardell initiated Tabula Rasa HealthCare with a Buy and a $19.50 price target.
07/10/17
07/10/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. SeaSpine (SPNE) initiated with a Buy at H.C. Wainwright. 2. Puma Biotechnology (PBYI) resumed with an Outperform at Leerink. 3. SCYNEXIS (SCYX) initiated with a Buy at Roth Capital. 4. Tabula Rasa HealthCare (TRHC) initiated with a Buy at Chardan. 5. Matinas BioPharma (MTNB) initiated with a Buy at Roth Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/30/17
UBSW
08/30/17
NO CHANGE
Target $25
UBSW
Buy
Tabula Rasa HealthCare price target raised to $25 from $18 at UBS
UBS analyst Michael Cherny raised his price target on Tabula Rasa HealthCare to $25 from $18 citing its continued execution on an expanding addressable market opportunity that could pivot the company towards a higher multiple. Cherny reiterated his Buy rating on Tabula Rasa shares.
09/07/17
WELS
09/07/17
DOWNGRADE
WELS
Market Perform
Tabula Rasa downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst Peter Costa downgraded Tabula Rasa HealthCare to Market Perform citing the SinfoniaRx acquisition. The analyst is cautious that Tabula may be going outside of its core business with this deal. He adds that potential earn-outs could represent up to almost double the original purchase price. Costa has a $21 price target for Tabula shares.

TODAY'S FREE FLY STORIES

ROKU

Roku

$22.19

-0.83 (-3.61%)

09:02
10/17/17
10/17
09:02
10/17/17
09:02
Hot Stocks
Roku expands further into Latin America, to launch two players in region »

Roku, Inc. announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEOT

Neothetics

$0.52

-0.0206 (-3.81%)

09:02
10/17/17
10/17
09:02
10/17/17
09:02
Hot Stocks
Neothetics, Evofem Biosciences announce all-stock merger »

Neothetics (NEOT) and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROKU

Roku

$22.19

-0.83 (-3.61%)

09:01
10/17/17
10/17
09:01
10/17/17
09:01
Hot Stocks
Roku launches Roku Express in Canada »

Roku, Inc. announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABEO

Abeona Therapeutics

$16.70

0.6 (3.73%)

09:01
10/17/17
10/17
09:01
10/17/17
09:01
Syndicate
Abeona Therapeutics 5M share Spot Secondary priced at $16.00 »

The deal range was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 23

    Oct

  • 17

    Oct

NFLX

Netflix

09:00
10/17/17
10/17
09:00
10/17/17
09:00
Recommendations
Netflix analyst commentary  »

Netflix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

09:00
10/17/17
10/17
09:00
10/17/17
09:00
General news
Fed funds futures are modestly lower, having unwound early gains »

Fed funds futures are…

09:00
10/17/17
10/17
09:00
10/17/17
09:00
General news
Industrial Production to be reported at 09:15 »

September Industrial…

09:00
10/17/17
10/17
09:00
10/17/17
09:00
General news
Industrial Production Capacity Utilization Rate to be reported at 09:15 »

September Industrial…

ACN

Accenture

$139.09

-0.11 (-0.08%)

08:59
10/17/17
10/17
08:59
10/17/17
08:59
Hot Stocks
Accenture enters into exclusive negotiations to acquire Altima »

Accenture has entered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

JNJ

Johnson & Johnson

$136.12

-0.31 (-0.23%)

08:59
10/17/17
10/17
08:59
10/17/17
08:59
Earnings
Johnson & Johnson backs FY17 revenue view $75.9B-$76.2B, consensus $75.83 »

Guidance in constant…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 23

    Oct

  • 27

    Oct

  • 06

    Nov

LRCX

Lam Research

$192.36

2.46 (1.30%)

08:59
10/17/17
10/17
08:59
10/17/17
08:59
Recommendations
Lam Research analyst commentary  »

Lam Research added to US…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

JNJ

Johnson & Johnson

$136.12

-0.31 (-0.23%)

08:57
10/17/17
10/17
08:57
10/17/17
08:57
Hot Stocks
Breaking Hot Stocks news story on Johnson & Johnson »

Johnson & Johnson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 23

    Oct

  • 27

    Oct

  • 06

    Nov

08:56
10/17/17
10/17
08:56
10/17/17
08:56
General news
Redbook Store Sales data reported »

Week of 10/14 Redbook…

SRPT

Sarepta

$50.73

0.16 (0.32%)

08:56
10/17/17
10/17
08:56
10/17/17
08:56
Recommendations
Sarepta analyst commentary  »

Sarepta approaching…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

NFLX

Netflix

$202.68

3.19 (1.60%)

, GE

General Electric

$23.36

0.38 (1.65%)

08:55
10/17/17
10/17
08:55
10/17/17
08:55
Options
Notable open interest changes for October 17th »

Monday's total…

NFLX

Netflix

$202.68

3.19 (1.60%)

GE

General Electric

$23.36

0.38 (1.65%)

CMCSA

Comcast

$36.61

0.6 (1.67%)

BAC

Bank of America

$26.24

0.41 (1.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 20

    Oct

  • 22

    Oct

  • 26

    Oct

  • 01

    Nov

08:55
10/17/17
10/17
08:55
10/17/17
08:55
General news
The U.S. trade price report beat estimates »

The U.S. trade price…

NOW

ServiceNow

$121.40

-0.89 (-0.73%)

08:55
10/17/17
10/17
08:55
10/17/17
08:55
Conference/Events
ServiceNow to hold a forum »

NowForum 2017 is being…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 25

    Oct

  • 26

    Oct

  • 11

    Dec

GSM

Ferroglobe

$14.56

0.39 (2.75%)

08:55
10/17/17
10/17
08:55
10/17/17
08:55
Conference/Events
Ferroglobe to hold investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 14

    Nov

  • 15

    Nov

MSBI

Midland States

$33.03

-0.07 (-0.21%)

08:55
10/17/17
10/17
08:55
10/17/17
08:55
Conference/Events
Midland States to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 27

    Oct

  • 15

    Nov

HPE

HP Enterprise

$14.86

-0.03 (-0.20%)

08:53
10/17/17
10/17
08:53
10/17/17
08:53
Initiation
HP Enterprise initiated  »

HP Enterprise initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 11

    Dec

JNJ

Johnson & Johnson

$136.12

-0.31 (-0.23%)

08:51
10/17/17
10/17
08:51
10/17/17
08:51
Hot Stocks
Johnson & Johnson says Puerto Rico hurricane had limited impact on company »

Says impact was limited…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 23

    Oct

  • 27

    Oct

  • 06

    Nov

PX

Praxair

$141.29

-0.92 (-0.65%)

08:51
10/17/17
10/17
08:51
10/17/17
08:51
Hot Stocks
Praxair signs long-term agreement to supply nitrogen to GLOBALFOUNDRIES »

Praxair has signed a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

ERII

Energy Recovery

$8.21

0.02 (0.24%)

08:49
10/17/17
10/17
08:49
10/17/17
08:49
Initiation
Energy Recovery initiated  »

Energy Recovery initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

  • 16

    May

JNJ

Johnson & Johnson

$136.12

-0.31 (-0.23%)

08:49
10/17/17
10/17
08:49
10/17/17
08:49
Hot Stocks
Breaking Hot Stocks news story on Johnson & Johnson »

Johnson & Johnson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 23

    Oct

  • 27

    Oct

  • 06

    Nov

CSX

CSX

$52.84

0.01 (0.02%)

08:49
10/17/17
10/17
08:49
10/17/17
08:49
Hot Stocks
CSX expects Q4 volume to be neutral »

CSX has a favorable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 29

    Oct

  • 30

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.